Protein encoded by adenovirus early region 1A (E1A) stimulates transcription from adenovirus promoters in vivo. Here we show that this effect can be observed in vitro. In a run-off transcription assay from the adenovirus serotype 2 (Ad2) major late promoter, extracts prepared 20 hr postinfection were 5-15 times more active than mock-infected-cell extracts prepared in parallel. Similar results were observed for in vitro transcription from the protein IX and E3 adenovfrus promoters, whereas a 2-fold increase was observed for the human ,-globin promoter. (26, 28, 29) . However, in one study using a transient transfection assay (30), and in another using microinjection of ElA proteins synthesized in Escherichia coli (16) (31) . The final ammonium sulfate precipitate from the ultracentrifugation supernatant was dialyzed for 12 hr against 500 volumes of 20 mM Hepes/NaOH, pH 7.9/0.1 M KC1/5 mM MgCl2/1 mM EDTA/1 mM dithiothreitol/17% (vol/vol) glycerol. After centrifugation at 10,000 X g for 10 min, the extracts were quick-frozen in dry ice in small aliquots and stored at -70°C. Extracts stored for 5 months retained full activity. Protein concentrations were determined by the method of Bradford (32).
Protein encoded by early region 1A (ElA) greatly stimulates transcription of adenovirus early genes (1) (2) (3) (4) . The mechanism of this trans-activation is not understood but is of considerable interest as an example of transcription regulation and because ElA functions are central to the process of oncogenic transformation by adenovirus (reviewed in ref. 5) . ElA protein activates genes transcribed by both RNA polymerase II and RNA polymerase III (6) (7) (8) , and cellular genes and the genes of other DNA viruses are also trans-activated (9) (10) (11) (12) (13) (14) (15) . The ElA proteins themselves do not appear to be DNA-binding proteins (16) . Systematic directed mutagenesis of adenovirus early promoters has not revealed a consensus DNA sequence required for ElA trans-activation (12, (17) (18) (19) (20) (21) (22) (23) . Rather, the implication of the promoter mutagenesis studies is that the same cellular DNA-binding transcription factors that interact with promoter elements in the absence of ElA proteins interact with these same promoter elements during ElA trans-activation. It appears that no additional DNAbinding proteins are required for ElA trans-activation.
The ElA region is complex (reviewed in ref. 24) . Messenger RNAs of 12 S and 13 S are expressed during the early phase of infection and an additional 9S mRNA is produced during the late phase. Each of these mRNAs has the same 5' and 3' sequences and differs from the others by the size of a single intron removed by RNA splicing. The 13S mRNA encodes a protein of 289 amino acids. The 12S mRNA encodes a protein of 243 amino acids identical in sequence to the 289-residue protein, except for the deletion of 46 amino acids from roughly the middle of the protein as the result of the alternative splicing of the 12S mRNA. Mutants that express only the 289-residue protein induce wild-type levels of early mRNA, demonstrating that neither the 243-residue ElA protein nor the potential translation product of the 9S mRNA are required for trans-activation (25) (26) (27) . Mutants that express only the 12S mRNA or the 12S mRNA and 9S mRNA are extremely defective in trans-activation, indicating that the 243-residue protein and the 9S mRNA product have much less trans-activating activity than the 289-residue protein (26, 28, 29) . However, in one study using a transient transfection assay (30) , and in another using microinjection of ElA proteins synthesized in Escherichia coli (16) (31) . The final ammonium sulfate precipitate from the ultracentrifugation supernatant was dialyzed for 12 hr against 500 volumes of 20 mM Hepes/NaOH, pH 7.9/0.1 M KC1/5 mM MgCl2/1 mM EDTA/1 mM dithiothreitol/17% (vol/vol) glycerol. After centrifugation at 10,000 X g for 10 min, the extracts were quick-frozen in dry ice in small aliquots and stored at -70°C. Extracts stored for 5 months retained full activity. Protein concentrations were determined by the method of Bradford (32) .
In Vitro Transcription and Analysis of RNA Products. Run-off transcription from the Ad2 MLP was assayed using pBalIE (31) cut at the Sma I site. Transcription from the E3 promoter was assayed using Ad5HindIIIB (33) (33) . Gels were dried and exposed to XAR (Kodak) film. The specific RNA run-off transcript was quantitated by densitometry (using a Hoefer densitometer) of films exposed to dried gels without intensifying screens under conditions where the band intensity was directly proportional to cpm (34) . Quantitation is shown in Table 1 . 6) . No 536-base product was produced by any of these extracts in the absence of added template (data not shown). In complete transcription reactions, production of the 536-base product was inhibited by a-amanitin (1 ,ug/ml), demonstrating that it is the product of RNA polymerase II (data not shown).
RESULTS
There was no detectable difference in the amount ofrun-off transcript synthesized by extracts from uninfected exponentially growing cells and mock-infected and Ad2-infected cells immediately after virus adsorption (Fig. 1, lanes 1-3) . The extract from cells 6 hpi was slightly more active than extracts tCultures were incubated at 39°C. §Cytosine arabinonucleoside (araC) was added at the time of infection or mock-infection and maintained at 20 jg/ml as described (36 (Table 1 ). The increased amount of run-off RNA synthesized by the infected-cell extracts was not due to reduced stability ofthe run-off RNA in the mock-infected-cell extracts. Pulse-chase experiments indicated that run-off transcript was stable for at least 2 hr in extracts of both uninfected and infected cells (data not shown). RNA polymerase II activities determined by an assay for strand elongation (37) were similar in Ad2-and mock-infected-cell extracts, as reported previously (59) . In the experiment shown in Fig. 1 , the activity of extracts prepared from mock-infected cells increased with time after mock-infection. This trend was observed in three of five time-course experiments and may have resulted from suspension of cells in fresh medium at the time of mock-infection. In two of five time courses, no increase or decrease in activity of the mock-infected extracts with time after infection was observed. In every case, however, there was at least 5 times higher activity of the extracts of Ad2-infected cells prepared at [14] [15] [16] [17] [18] [19] [20] hpi. (38, 39) ] and cultured for 20 hr at 39TC (the nonpermissive temperature), and whole-cell extracts were prepared. Production of viral late proteins was assayed by immunoblotting of the extract, using an antiserum raised against Ad2 virions. As expected, the production of virion proteins was greatly diminished in ts125-infected cells at the nonpermissive temperature (data not shown). Even though these conditions inhibited viral late-gene expression, the in vitro transcriptional activity of the infected-cell extracts was again at least 5 times higher than the activity of extracts of uninfected cells ( Fig. 2 (25) . Extracts from mock-, d11312-, and d11500-infected cells had similar activities (Fig. 3) . In contrast, there was an increase in the amount of run-off RNA synthesized in extracts of Ad2-and pm975-infected cells ( Fig. 3 infected HeLa cell extracts. Expression of the 243-residue ElA protein was not required, nor was it sufficient to produce the higher activity.
We also analyzed the production of viral late proteins in d11500-infected cells by immunoblotting of cell extracts, using antiserum to Ad2 virions as described in the previous section. The level of late proteins in d11500-infected cells was similar to that observed in ts125-infected cells (data not shown), yet the transcriptional activity of ts125-infected cell extracts was much greater than that of d11500-infected cell extracts. These results provide further evidence that viral late proteins are not responsible for the increased transcriptional activity of adenovirus-infected cell extracts.
Transcriptional Activity with Other Promoters. The transcription reaction results described so far were obtained from the Ad2 MLP. To determine whether the increased transcriptional activity in the infected-cell extract was gene-specific, we examined other genes transcribed by RNA (1, (46) (47) (48) . Consequently, it is very likely that the increased transcriptional activity of infected-cell extracts observed here is due to the same phenomenon that causes the ElA trans-activation observed in vivo.
ElA protein does not appear to stimulate transcription by interaction with specific sequences in promoter regions (9, 12, (17) (18) (19) (20) (21) . Indeed, ElA proteins do not appear to be DNA-binding proteins (16) . Rather, the results of promotermutagenesis experiments suggest that ElA proteins act via cellular, sequence-specific DNA-binding proteins (17) (18) (19) (20) (21) . The Ad2 MLP is among the best-studied promoters. Maximal rates of transcription from this promoter in vitro requires at least five proteins in addition to RNA polymerase 11 (49) (50) (51) (52) (53) (54) . Two of these are sequence-specific DNA-binding proteins, one interacting with an upstream promoter element at -63 to -53 (52) (53) (54) , and the other a "TATA-box"-binding-protein (51, 52) . The same sequences identified by interaction with these cellular transcription factors in vitro are the only sequences required for ElA-stimulated transcription from the MLP in vivo (23) . One model by which ElA protein might stimulate transcription from the MLP is by increasing the frequency of transcription initiation by RNA polymerase II from transcription complexes composed of MLP DNA and bound transcription factors. Alternatively, ElA protein might act by increasing the number of DNA molecules assembled into transcription complexes (36) . Other, more complex models of ElA trans-activation are also consistent with the genetic data.
Our analysis ofthe transcriptional activities of infected-cell extracts bears directly on a choice between these models. The 5-fold higher transcriptional activity of infected-cell extracts prepared 20 hpi was due to a 5-fold increase in the number of transcribed templates. This follows from the observation that the number of run-off RNA molecules synthesized was 5-fold greater for the infected-cell extract (55) have recently reported findings, from a very different type of study, that also suggest that ElA expression results in an increase in the number of transcription complexes formed on a viral early promoter. They assayed transcription-complex formation on the E2A early promoter by observing a block to exonuclease III digestion of viral DNA in nuclei isolated from infected cells. A block to exonuclease digestion in the E2A promoter region was much more apparent in nuclei from cells infected with wild-type Ad2 than in nuclei from cells infected with the ElA deletion mutant d1312 (55) .
How might the expression of ElA protein result in an increase in the number of transcription complexes assembled from cellular transcription factors and infecting viral DNA? Several possible mechanisms are consistent with the available data. ElA protein could increase the rate of interaction between cellular transcription factors and viral early promoters, a model suggested earlier on the basis of in vivo experiments (36) . Alternatively, the concentration of free active transcription factors in uninfected cells might be very low and ElA protein might act by causing an increase in the number of active transcription factors. Finally, ElA protein might function by inactivating an inhibitor of transcription (3) . An analysis of the activities of transcription factors for genes transcribed by RNA polymerase III in extracts of infected and mock-infected HeLa cells suggested that the higher RNA polymerase III specific transcriptional activity of infected-cell extracts is due to an increase in the amount of the limiting class III transcription factor, TFIIIC (56) . Based on these results, we presently favor the model that ElA expression results in an increase in the number of active transcription factors in infected cells, either by inducing the synthesis of transcription factors or by converting a pool of inactive transcription factors into active ones. From the results reported here, we cannot distinguish whether the higher activities of infected-cell extracts result from the action of ElA protein in vivo or in vitro. As yet, we have not observed stimulation of the in vitro transcriptional activity of uninfected HeLa cell extracts by addition of ElA proteins partially purified from infected cells (A. Tsukamoto and A.J.B., unpublished results) or purified from engineered E. coli (4 
